Back to top
more

Assure (IONM)

(Delayed Data from OTC)

$0.10 USD

0.10
15

+0.03 (43.11%)

Updated Nov 1, 2024 03:01 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (149 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Inotiv, Inc. (NOTV) Q3 Earnings Miss Estimates

by Zacks Equity Research

Inotiv, Inc. (NOTV) delivered earnings and revenue surprises of -73.08% and 6.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

The Beauty Health Company (SKIN) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

The Beauty Health Company (SKIN) delivered earnings and revenue surprises of 40% and 0.91%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

ModivCare (MODV) Misses Q2 Earnings Estimates

by Zacks Equity Research

ModivCare (MODV) delivered earnings and revenue surprises of -2.65% and 7.90%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

NovoCure (NVCR) delivered earnings and revenue surprises of -8% and 2.38%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Sharecare, Inc. (SHCR) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Sharecare, Inc. (SHCR) delivered earnings and revenue surprises of 25% and 4.66%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Ascend Wellness Holdings, Inc. (AAWH) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Ascend Wellness Holdings, Inc. (AAWH) delivered earnings and revenue surprises of -100% and 4.65%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

LumiraDx Limited (LMDX) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

LumiraDx Limited (LMDX) delivered earnings and revenue surprises of -68.42% and 7.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

The Beauty Health Company (SKIN) Q4 Earnings Meet Estimates

by Zacks Equity Research

The Beauty Health Company (SKIN) delivered earnings and revenue surprises of 0% and 3.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

CareDx (CDNA) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

CareDx (CDNA) delivered earnings and revenue surprises of -16.67% and 0.38%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Assure Holdings Corp. (IONM) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of -28.57% and 17.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CoDiagnostics, Inc. (CODX) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 33.33% and 24.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Brookdale Senior Living (BKD) Reports Q3 Loss

by Zacks Equity Research

Brookdale (BKD) delivered earnings and revenue surprises of -15.38% and 0%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Assure Holdings Corp. (IONM) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of -60.87% and 72.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

OYSTER PT PHARM (OYST) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

OYSTER PT PHARM (OYST) delivered earnings and revenue surprises of -14.02% and 2.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

LifeStance Health Group (LFST) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

LifeStance Health (LFST) delivered earnings and revenue surprises of -58.33% and 1.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Progyny (PGNY) delivered earnings and revenue surprises of 350% and 2.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Assure Holdings Corp. (IONM) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of -216.67% and 27.68%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Armata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Armata Pharmaceuticals, Inc. (ARMP) delivered earnings and revenue surprises of -50% and 30.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OncoCyte (OCX) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

OncoCyte (OCX) delivered earnings and revenue surprises of 15.38% and 16.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Agiliti (AGTI) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Agiliti (AGTI) delivered earnings and revenue surprises of 26.09% and 0.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Progyny (PGNY) delivered earnings and revenue surprises of 150% and 2.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Premier, Inc. (PINC) Matches Q3 Earnings Estimates

by Zacks Equity Research

Premier, Inc. (PINC) delivered earnings and revenue surprises of 0% and 2.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Tivity Health (TVTY) Moves 5.2% Higher: Will This Strength Last?

by Zacks Equity Research

Tivity Health (TVTY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Assure Holdings Corp. (IONM) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of -50% and 8.53%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Assure Holdings Corp. (IONM): Can Its 7.3% Jump Turn into More Strength?

by Zacks Equity Research

Assure Holdings Corp. (IONM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.